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509 - Viruses as the cause of cancer
IMoS361 Epidemiology of genital Human Papillomavirus
infection and risk for development of cancer
Joakim Dillner
The Microbiology & Tumor Biology Center, Karolinska Institute, Stockholm,
Sweden
Infection with the oncogenic types of Human Papillomavirus (HPV),
particularly type 16, is established as the major cause ofcervical intraepithe-
lial nroplasia (CIN) and invasive cervical cancer. In recent years, several
prospective studies have also implicated HPV 16 infection as a major cause of
vulvar, vaginal, anal, penile, fmgertip and tonsillar cancers.
The vast majority of infections arc transient and become undetectable
within t - 2 years. A persistent infection with continued active expression of
the viral transforming proteins is considered a necessary step in the
pathogenesis of cervical cancer.
The major mode of transmission is sexual: Infection with oncogenic HPV
types can not be demonstrated in virginal women, neither by serology nor
by HPV DNA detection. About t % of children in presexually active ages
are seropositive.
The seroprevalence ofthe infection shows a rapid increase in the ages after
coitarche. In Sweden, the HPV 16 seroprevalence is linearly dependent on
the lifetime number of sexual partners, increasing with about 4%/sexual
parmer. Seropositivity is stable over time also after viral clearance and
correlates with cumulative life-time HPV exposure.
HPV seroprevalence correlates with seroprevalence of other STDs, such
as Chlamydia or HSV-2, and there has been a concomitant increase ofHPV
seroprevalence and seroprevalence ofother STDs between the I%O:ies to the
1980:ies in the Nordic countries.
A cervical HPV DNA-positive woman has a > tOO-fold excess risk to
have an existent cervical neoplasia and a t6-fold excess risk to develop
invasive cervical cancer in the future.
Possible preventive actions that are presently being evaluated include
organized screening for HPV infection and prophylactic HPV vaccination.
IMoS3S1 Hepatitis Band Cviruses and cancer
Ma C. Kew
University of the Witwatersralld, Johannesburg, South Africa
Of the currently recognised hepatotropic viruses, only hepatitis Band C
viruses are known to cause hepatocellular cancer in humans. Hepatocarci-
nogenesis is a C'o.mplex stcpmsc proc~!; that evolves over several or many
years and precisely how hepatitis viruses contribute to this process is
uncertain. There is, however, mounting evidence that both direct and
indirect carcinogenic mechanisms are involved with both viruses. Chronic
necroinflammatory disease, in the form of cirrhosis or occasionally chronic
hepatitis, induced by both hepatitis Band C viruses, acts as a tumour
promoter by markedly increasing the hepatocyte turnover rate, modifying
normal cell-to-cell and cell-to-extracellular matrix interactions, impairing
DNA repair processes, and generating mutagenic oxygen reactive species.
Hepatitis B virus is a DNA virus that is integrated into cellular DNA in the
great majority of hepatitis B virus-related hepatocellular carcinomas, and
there is increasing evidence that its direct oncogenic effect is mediated by the
X protein that is expressed from integrated viral DNA. This protein
transactivates a number of cellular genes and may thus influence cellular
proliferation and differentiation or apoptosis. It also compromises DNA
repair and may allow the accumulation of potentially transforming muta-
tions. Insertional mutagenesis In cis may playa pathogenetic role in a small
percentage of tumours. In contrast, hepatitis C virus is an RNA virus that
does not integrate into cellular DNA and there is less evidence that it is
directly oncogenic. There is, however, emerging evidence that the core
protein and NS3 protein may exert a transforming effect from an extra-
chromosomal position. Hepatitis Band C viruses interact synergistically in
the pathogenesis of hepatocellular carcinoma.
510 - New diagnostics and therapeutic approaches ...
IMoS391 Definitions of invasive fungal infections
Sibel Ascioglu
Hacettepe University, Dept. of Infectious Diseases, Ankara, Turkey
Clinical research addressing the epidemiology, diagnosis and treatment of
invasive fungal infections (IFl) is accumulating in the medical literature.
Unfortunately, differences in definitions, nomenclature, and diagnostic
criteria complicate comparison ofresults and collaboration between centers.
Therefore EORTC/IFICG launched a project to reach a consensus on
definitions of IF! in cancer patients. The purpose of this effort was to
improve the ability to compare protocols, therapeutic interventions and
eliminate confusion in communication for both clinicians and researchers by
standardizing the definitions. This project has been designed and proceeded
in three steps: (1) Defining the problem. (2) Assessing the current preferences
among investigators in defming and classifying IF!. (3) Composing a new
proposal for definitions ofIF!.
A task force was created in t997 to systematically review the literature,
describe problems related to heterogeneity ofstudy populations, and abstract
previously used definitions of IF!. The task force was composed of 12
members of IFICG and later with the invited members of NIAID/MSG
formed a consensus committee. As a result ofjoint efforts of the committee
members, a new clas..ification based on the level ofcertainty for the diagnosis
ofIFI was devised. This proposal includes both diagnostic criteria for proven
IFl and also classification criteria for probable and possible diseases. Three
elements formed the basis of these definitions: host factors, clinical features
and microbiological results. We have chosen a format that is easy and flexible
to apply to individual patients in daily clinical practice.
IMoS40 I Diagnostic options for early detection of invasive
aspergillosis
P. E. Verweij
Departmmt ofMedical Microbiology, University Medical Cmter 8t Radboud,
Nijmegm, Netherlands
The early diagnosis ofinvasive aspergillosis (IA) is very important in order to
start antifungal treatment promptly. Since the yield of conventional diag-
nostic tests is low, most patients who are suspected for invasive fungal
infection are treated empirically. This approach may allow early treatment
of patients with IA but also results in unnecessary treatment ofa significant
proportion of patients with infection. These patients are exposed to drug-
related toxicity especially if amphotericin B desoxycholate is used for
primary therapy. A management strategy that allows a better selection of
patients that require antifungal therapy is desirable. Improved selection of
patients that require antifungal therapy can be achieved if they are system-
atically screened during the period ofhigh risk for the presence ofa marker
that is indicative of IA. Patients' blood can be screened regularly for the
presence ofcirculating Aspergillus antigen or DNA. Once antigen or DNA is
detected additional diagnostic procedures such a. high resolution CT ><:an
can be used to confirm the presence of infection. Patients with confirmed
disease can be treated pre-emptively. The assays that are used to screen
patients have to be both sensitive and specific, and both antigen detection and
PCR appear to perform well in this respect. However, several issues need to
be resolved before prospective screening of patients can be implemented.
Furthermore, the performance of antigen or DNA detection has been
evaluated almost exclusively in patients with hematological malignancies,
but other patient groups at risk remain to be investigated.
IMoS411 Surveillance of nosocomial fungal infections
Patricia Munoz
Hospital General Universitario "Gregorio Maranon", Madrid, Spain
Nosocomial fungal infections caused by Candida, Aspergillus or new multi-
resistant pathogens are on the rise. They still cause a very high morbidity and
mortality proving that our therapeutic and prophylactic measures lack
efficacy. Epidemiological surveillance for nosocomial micoses is highly
recommended and should include the periodic review of hopital's micro-
biologic, histopathologic and postmortem data. A very high index of
suspicion for prompt diagnosis in high-risk patients is also desirable.
Previous colonization is a recognized risk factor for developing invasive
candidiasis or aspergillosis, although the positive and negative predictive
values of these cultures are different for each group of patients at risk.
Molecular-biology methodology may detect the presence of fungus more
accurately than culture and serological methods. They may also be helpful in
the analysis of outbreaks and nosocomial transmission. However, the cost-
effectivenes of microbiological surveillance out of an outbreak situation
remains an unresolved issue. Environmental culturing for Aspe"lillu$
organisms may be useful to detect failures in air-quality conrrol measures
